A Study in Participants With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 978 participants.
Also called NCT01064687
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 978 participants
- Sponsor
- Registry
-
NCT01064687
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Mexico, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT01064687. Randomized; quadruple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2015-01-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Participants With Type 2 Diabetes Mellitus
- Acronym
- AWARD-1
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2189265
- Intervention (Drug)
- Exenatide
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Pioglitazone
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01064687- Content hash
fa5d45695713b30775710e1ab2e040b5514d5fd1c065ea64a26bb490e280c808